TrialReader


Does Hyaluronic Acid Affect Periodontal Treatment?

NCT03754010 — Phase 1, Completed, 24 participants, Yuzuncu Yil University

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

Evaluation of Clinical and Biochemical Effects of Hyaluronic Acid on Periodontitis: A Split-mouth Randomized-controlled Trial

RegistryNCT03754010
StatusCompleted
PhasePhase 1
Study typeInterventional; randomized, crossover, masking: triple, treatment
Enrollment24 (Actual)
SponsorYuzuncu Yil University (Other)
ConditionsPeriodontitis
InterventionsScaling and root planning, Hyaluronic acid gel (HA) and SRP, HA mouthrinse and SRP, HA mouthrinse+gel and SRP (Procedure, drug)
Datesstart 2017-08-30, primary completion 2018-04-30, completion 2018-09-30, first posted 2018-11-27, last updated 2018-11-27
Locations1 site in Turkey (Türkiye)

Related Papers Related Patents Related Grants Related Experts
AI Assistant Save
All trials for Periodontitis All trials of Scaling and root planning All trials of Hyaluronic acid gel (HA) and SRP

-Summary

Objective: The aim of this study is to evaluate the effect of HA as an adjunct to scaling and root planning (SRP) on clinical parameters, periodontal inflamed surface area (PISA) and adenosine deaminase (ADA), catalase (CAT), and glutathione (GSH) levels in gingival crevicular fluid (GCF) in patients with periodontitis.

Expand all sections  ·  Collapse all

+Detailed description

Design: A total of 24 Stage II-III periodontitis patients will be included in this split-mouth, randomized-controlled study. The study population will be divided into four groups: in Group 1 (SRP): SRP+ saline; in Group 2 (SRP+HAgel): SRP + HA gel; in Group 3 (SRP+HAmo): SRP+ HA mouthrinse; and in Group 4 (SRP+HAmo+HAgel): SRP+HA mouthrinse + HA gingival gel were applied. At baseline and Week 4 periodontal clinical parameters and PISA will be calculated. Also, GCF amount will be collected to evaluate ADA, CAT, and GSH by spectrophotometric analysis.

+Arms and interventions

ArmTypeInterventionsDescription
Scaling and root planning (SRP)Placebo comparatorProcedure: Scaling and root planningUnder local anesthesia, full-mouth SRP was performed within 24 h in a single or two sessions using ultrasonic and hand instruments (Gracey, Hu-Friedy, Chicago, IL, USA) by a single investigator (DA). Immediately after the SRP, HA gel (Gengigel, Hyaluronic acid, gingival gel, Ricefarma S.R.L, Italy) or mouthrinse was performed according to the groups' procedure. In Group 1, the periodontal sulcus was irrigated with saline solution after SRP.
Hyaluronic acid gel (HA) and SRPExperimentalProcedure: Scaling and root planning; Drug: Hyaluronic acid gel (HA) and SRPGroup 2, after SRP was performed and irrigated with saline the area was dried with a soft air and, then, a gel containing HA was applied intrasulcular.
HA mouthrinse and SRPExperimentalProcedure: Scaling and root planning; Drug: HA mouthrinse and SRPIn Group 3, HA hydrogel mouthrinse (Gengigel, Hyaluronic acid, Hydrogel moutrinse for gums, Ricefarma S.R.L, Italy) were used as an irrigator after SRP.
HA mouthrinse+gel and SRPExperimentalProcedure: Scaling and root planning; Drug: HA mouthrinse+gel and SRPIn Group 4, after SRP was performed, the sulcus was irrigated with HA hydrogel mouthrinse and, then, intrasulculary HA gingival gel was applied.
  • Scaling and root planning (Procedure): Under local anesthesia, full-mouth SRP will be performed by a single investigator. Immediately after the SRP, HA gel or mouthrinse will perform according to the groups' procedure. In Group 1, the periodontal sulcus will be irrigated with saline solution after SRP.
  • Hyaluronic acid gel (HA) and SRP (Drug), also known as HA and SRP: In Group 2, after SRP will be performed and irrigated with saline the area was dried with a soft air and, then, a gel containing HA will be applied intrasulcular.
  • HA mouthrinse and SRP (Drug), also known as HAmo+SRP: In Group 3, HA hydrogel mouthrinse will be used as an irrigator after SRP.
  • HA mouthrinse+gel and SRP (Drug), also known as HAmo+HAgel+SRP: In Group 4, after SRP will be performed, the sulcus was irrigated with HA hydrogel mouthrinse and, then, intrasulculary HA gingival gel will be applied.

+Outcome measures

Primary outcomes

  • plaque index [Change from Baseline to week 4]: in accordance with the Sillness and Löe index (Silness \& Löe, 1964)
  • gingival index (GI) [Change from Baseline to week 4]: confirming to Silness and Löe index (Löe \& Silness, 1963)
  • bleeding on probing (BOP) [Change from Baseline to week 4]: according to Ainoma and Bay (AINAMO \& Bay, 1975);
  • Probing depth (PD) [Change from Baseline to week 4]: as the measurement of the length between the bottom of the periodontal pocket to marginal gingiva;
  • gingival recession height (GRH) [Change from Baseline to week 4]: as the measurement of the distance between the marginal gingiva and cemento-enamel junction
  • clinical attachment level (CAL) [Change from Baseline to week 4]: as the sum of gingival recession height and probing depth will be recorded.

Secondary outcomes

  • Changes of Periodontal inflammed surface area [Change from Baseline Baseline to week 4]: All clinical parameters will be entered on Microsoft Excel Program (www.parsprototo.info) which constructed for calculating PISA. The BOP percentage for each tooth will be calculated by entering "number sites with BOP" values in the Excel program.
  • Changes of Adenosine deaminase (ADA) levels in gingival crevicular fluid [Changes from Baseline to week 1,2,4]: The ADA activity will be evaluated spectrophotometrically
  • Changes of Catalase levels in gingival crevicular fluid [Changes from Baseline to week 1,2,4]: The catalase activity will be evaluated spectrophotometrically
  • Changes of Glutathione levels in gingival crevicular fluid [Changes from Baseline to week 1,2,4]: The Glutathione activity will be evaluated spectrophotometrically

+Eligibility

Sex: All, ages: 18 Years to 55 Years

Inclusion Criteria:

* Systemically healthy
* moderate-to-severe periodontitis
* at least five sites with ≥5mm probing depth (PD)
* at least ≥20 teeth
* Stage II-III periodontitis according to the 2017 World Workshop
* Age between18-55

Exclusion Criteria:

* receiving systemic or local antibiotics within the past six months
* prior surgical or non-surgical periodontal treatment within the past six months
* smoking
* pregnancy
* lactation
* age ≤18 years or ≥55 years
* hypertension
* known chronic systemic diseases (i.e., diabetes mellitus, rheumatoid arthritis), - - known hypersensitivity to one of the ingredients of the HA preparation.

+Locations (1)

FacilityCityCountryStatus
Van Yuzuncu Yil University Faculty of DentistryVanTurkey (Türkiye)

+Publications

  • Results publication: Aydinyurt HS, Akbal D, Altindal D, Bozoglan A, Ertugrul AS, Demir H. Evaluation of biochemical and clinical effects of hyaluronic acid on non-surgical periodontal treatment: a randomized controlled trial. Ir J Med Sci. 2020 Nov;189(4):1485-1494. doi: 10.1007/s11845-020-02230-6. Epub 2020 May 21. PMID 32436173

+Investigators

My Notes